Bayer EBIT 2010-2024 | BAYRY

Bayer EBIT for the quarter ending December 31, 2024 was $1.798B, a 25.85% decline year-over-year.

  • Bayer 2024 EBIT was -0.077B, a 111.6% decline from 2023.
  • Bayer 2023 EBIT was 0.662B, a 91.03% decline from 2022.
  • Bayer 2022 EBIT was 7.388B, a 86.24% increase from 2021.

EBIT can be defined as earnings before interest and taxes.

Bayer EBIT 2010-2024 | BAYRY

  • Bayer 2024 EBIT was -0.077B, a 111.6% decline from 2023.
  • Bayer 2023 EBIT was 0.662B, a 91.03% decline from 2022.
  • Bayer 2022 EBIT was 7.388B, a 86.24% increase from 2021.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Innoviva (INVA)$1.1B